Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9626
PUT
Liberty Latin America Class C
LILAK
$1.65B
| $298K | ﹤0.01% |
51,700
+14,080
| +37% | +$102K |
|
9627
PUT
Protara Therapeutics
TARA
$235M
| $298K | ﹤0.01% |
56,400
+54,600
| +3,033% | +$176K |
|
9628
PUT
Kingstone Companies
KINS
$288M
| $298K | ﹤0.01% |
19,600
+13,700
| +232% | +$174K |
|
9629
CALL
Coherus Oncology
CHRS
$178M
| $297K | ﹤0.01% |
215,500
+186,200
| +635% | +$209K |
|
|
BCIC
9630
PUT
BCP Investment Corp
BCIC
$94.5M
| $297K | ﹤0.01% |
18,200
+12,500
| +219% | +$219K |
|
|
ALE
9631
DELISTED
Allete
ALE
| $297K | ﹤0.01% |
4,589
-7,439
| -62% | -$480K |
|
9632
ProShares Ultra Technology
ROM
$1.32B
| $297K | ﹤0.01% |
4,258
+2,867
| +206% | +$202K |
|
9633
AdvisorShares Focused Equity ETF
CWS
$134M
| $297K | ﹤0.01% |
+4,584
| New | +$316K |
|
9634
American Battery Technology Co
ABAT
$331M
| $297K | ﹤0.01% |
+120,671
| New | +$135K |
|
9635
First Commonwealth Financial
FCF
$2.17B
| $297K | ﹤0.01% |
17,540
-31,454
| -64% | -$556K |
|
|
DSL
9636
PUT
DoubleLine Income Solutions Fund
DSL
$1.24B
| $297K | ﹤0.01% |
23,600
+12,800
| +119% | +$163K |
|
9637
CALL
Global X FinTech ETF
FINX
$168M
| $297K | ﹤0.01% |
+9,500
| New | +$297K |
|
9638
PUT
Vericel Corp
VCEL
$2.23B
| $297K | ﹤0.01% |
5,400
-10,700
| -66% | -$542K |
|
9639
CALL
Astrana Health
ASTH
$1.97B
| $296K | ﹤0.01% |
9,400
-576,900
| -98% | -$27.4M |
|
9640
PUT
Mama's Creations
MAMA
$803M
| $296K | ﹤0.01% |
37,200
+15,800
| +74% | +$131K |
|
9641
PUT
Teucrium Sugar Fund
CANE
$54.4M
| $296K | ﹤0.01% |
25,900
+9,300
| +56% | +$117K |
|
9642
CALL
Worthington Steel
WS
$1.93B
| $296K | ﹤0.01% |
9,300
+3,100
| +50% | +$121K |
|
9643
CALL
Regency Centers
REG
$14B
| $296K | ﹤0.01% |
4,000
+1,200
| +43% | +$87.8K |
|
|
EU
9644
enCore Energy
EU
$220M
| $295K | ﹤0.01% |
86,620
-52,611
| -38% | -$198K |
|
|
FCTE
9645
SMI 3Fourteen Full-Cycle Trend ETF
FCTE
$250M
| $295K | ﹤0.01% |
+11,388
| New | +$307K |
|
|
MRC
9646
CALL
DELISTED
MRC Global
MRC
| $295K | ﹤0.01% |
23,100
+4,500
| +24% | +$58.9K |
|
9647
PUT
Graco
GGG
$13.2B
| $295K | ﹤0.01% |
3,500
+3,200
| +1,067% | +$277K |
|
9648
Pacer Swan SOS Moderate January ETF
PSMD
$94.4M
| $295K | ﹤0.01% |
10,117
-11,150
| -52% | -$322K |
|
|
ACGR
9649
American Century Large Cap Growth ETF
ACGR
$10.7M
| $295K | ﹤0.01% |
5,103
-215
| -4% | -$12.3K |
|
9650
PUT
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.42B
| $295K | ﹤0.01% |
6,100
+1,000
| +20% | +$50K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.